Market Size of China Bariatric Surgery Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 14.20 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
China Bariatric Surgery Market Analysis
The Chinese bariatric surgery market is expected to register a CAGR of 14.2% over the forecast period.
The COVID-19 pandemic had a significant impact on the growth of the market. Diagnostic and surgical companies were impacted by the lockdown measures within the country, which also decreased public mobility in China, resulting in fewer surgical procedures. According to the study published in September 2022 by Obesity Surgery, the number of bariatric surgeons and institutions increased more than threefold from 2010. In 2010, 2019, and 2020, surgeons in IFSO-APC societies performed 18,280, 66,010, and 49,553 bariatric/metabolic surgeries, respectively. However, due to the COVID-19 pandemic, restriction policies significantly reduced access to procedures in Southeast Asian countries. Thus, many COVID-19-positive patients and their significant impact on healthcare systems across the country resulted in a decline in the number of bariatric procedures performed, adversely impacting market growth in 2020 and slightly in 2021. However, analysis shows that the market gained traction after the pandemic and is expected to reach its pre-pandemic levels.
The major factors attributed to the growth of the Chinese bariatric surgery market are increased obesity levels among the Chinese population and a rising prevalence rate of Type 2 diabetes and heart diseases. People with more fatty tissues in their bodies are highly likely to be affected by diabetes. Hence, these patients take certain measures to prevent obesity through bariatric surgeries. For instance, according to the updates from August 2021 by the International Diabetes Federation, an estimated 1.08 billion people aged 20 to 79 in China had diabetes in 2021, by far the highest number in any country. The country had about 336 million children and adolescents up to 19 years old with type 1 diabetes (T1DM). Some major risk factors for T1DM include a family history of diabetes, genetics, infections, and other environmental influences. Hence, the high burden of diabetes linked to obesity and the increasing prevalence of risk factors associated with obesity are expected to fuel growth in the bariatric surgery market in China over the forecast period.
Moreover, according to the study published in June 2021 by Frontiers in Endocrinology in China, over one in seven individuals meet the criteria for overall obesity and one in three for abdominal obesity. Age-standardized rates of overall and abdominal obesity were 14.4% and 32.7% in women, respectively, and 16.0% and 36.6% in men. Obesity varied considerably across socio-demographic subgroups. Older women were at higher risk for obesity than women aged 65-75 versus 35-44 years (1.29 for overall obesity and 1.76 for abdominal obesity), while older men were not. As a result, the market for bariatric surgery is anticipated to grow over the forecast period due to the rising prevalence of obesity and the increased need for surgical procedures.
However, the high cost of surgery is expected to hinder the growth of the market over the forecast period.
China Bariatric Surgery Industry Segmentation
Bariatric surgery is a medical procedure that aids weight loss by either limiting the capacity of the stomach or the absorption of calories. This is the most effective weight-loss therapy for patients with morbid obesity and involves either open or laparoscopic techniques.
The Chinese bariatric surgery market is segmented by the device (assisting devices (suturing devices, closure devices, stapling devices, trocars, and other assisting devices), implantable devices (gastric bands, electrical stimulation devices, gastric balloons, gastric emptying), other devices). The report offers the market sizes and forecasts in terms of value in USD million.
By Device | |||||||
| |||||||
| |||||||
Other Devices |
China Bariatric Surgery Market Size Summary
The Chinese bariatric surgery market is poised for significant growth, driven by increasing obesity rates and the rising prevalence of Type 2 diabetes and heart diseases among the population. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a decrease in surgical procedures due to lockdowns and reduced public mobility. However, the market has since regained momentum and is expected to reach pre-pandemic levels. The demand for bariatric surgery is further fueled by the high number of individuals with diabetes and obesity, which are closely linked. The market is characterized by a competitive landscape, with major players innovating non-invasive technologies and expanding their product portfolios through strategic acquisitions.
The market's growth is also supported by advancements in medical devices, such as stapling devices, which are anticipated to show higher growth rates due to their effectiveness in achieving consistent weight loss and reducing obesity-related health issues. The introduction of new products, increased patient awareness, and collaborations with bariatric surgery centers are driving the demand for gastric balloons, a non-invasive weight loss tool. The market is expected to benefit from ongoing research and development, as evidenced by multiple clinical trials for gastric balloons in China. Despite the high cost of surgery posing a challenge, the overall outlook for the Chinese bariatric surgery market remains positive, with significant growth anticipated over the forecast period.
China Bariatric Surgery Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increase in Obesity Patients
-
1.2.2 Rising Prevalence of Type 2 Diabetes and Heart Diseases
-
1.2.3 Government Programmes and Policies Related to Obesity
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Surgery
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Device
-
2.1.1 Assisting Devices
-
2.1.1.1 Suturing Devices
-
2.1.1.2 Closure Devices
-
2.1.1.3 Stapling Devices
-
2.1.1.4 Trocars
-
2.1.1.5 Other Assisting Devices
-
-
2.1.2 Implantable Devices
-
2.1.2.1 Gastric Bands
-
2.1.2.2 Electrical Stimulation Devices
-
2.1.2.3 Gastric Balloons
-
2.1.2.4 Gastric Emptying
-
-
2.1.3 Other Devices
-
-
China Bariatric Surgery Market Size FAQs
What is the current China Bariatric Surgery Market size?
The China Bariatric Surgery Market is projected to register a CAGR of 14.20% during the forecast period (2024-2029)
Who are the key players in China Bariatric Surgery Market?
Cousin Biotech, Olympus Corporation, ReShape Lifesciences Inc, Reach surgical and Changzhou Haiers Medical Devices Co., Ltd. are the major companies operating in the China Bariatric Surgery Market.